Shinva Medical Instrument Co., Ltd announced it will acquire a 36.1913% stake in Wuhan Zhongzhi Biotechnologies Inc. for RMB166.5 million (USD22.8 million) to expand its in vitro diagnostics (IVD) product pipeline.